How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,554 results for

E/M Examination Criteria

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Criteria for appropriate use of FDG-PET in colorectal cancer

in the overall evidence for each outcome of interest. The GRADE approach for diagnostic recommendations was also used to elicit judgement from the panel members on benefit and harms trade-off for patient-important outcomes. The RAND method was used to vote and reach an agreement on the appropriateness criteria. Results: The panel examined and assessed the role of FDG-PET for the following 7 clinical indications: N staging of primary esophageal cancer; M staging of primary esophageal cancer; Target volume (...) . Criteria for appropriate use of FDG-PET in colorectal cancer . Bologna: Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR). ORIentamenti 5. 2011 Authors' conclusions Aim: The criteria reported in this document, are to be intended as guidance for programs of clinical governance aimed at: supporting clinicians on the use of FDG-PET; post hoc analyses of appropriate use of FDG-PET; contributing to the planning of the regional health service. Method: A panel of 26 experts, comprising

2011 Health Technology Assessment (HTA) Database.

62. Criteria for appropriate use of FDG-PET in breast cancer

of confidence in the overall evidence for each outcome of interest. The GRADE approach for diagnostic recommendations was also used to elicit judgement from the panel members on benefit and harms trade-off for patient-important outcomes. The RAND method was used to vote and reach an agreement on the appropriateness criteria. Results: The panel examined and assessed the role of FDG-PET for the following 7 clinical indications: Diagnosis of primary breast cancer; N staging of primary breast cancer; M staging (...) , Longo G. Criteria for appropriate use of FDG-PET in breast cancer . Bologna: Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR). ORIentamenti 3. 2011 Authors' conclusions Aim: The criteria reported in this document, are to be intended as guidance for programs of clinical governance aimed at: supporting clinicians on the use of FDG-PET; post hoc analyses of appropriate use of FDG-PET; contributing to the planning of the regional health service. Method: A panel of 23 experts

2011 Health Technology Assessment (HTA) Database.

63. A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers

information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Key Inclusion Criteria Part A: Males and females 18 to 50 years of age, inclusive Body mass index (BMI) from 18.5 to <30.0 kg/m^2 Participant is judged by the investigator to be in good health and free from major comorbidities based on medical history, physical examination, laboratory safety tests performed (...) at screening and/or prior to administration of initial dose of study drug Part B: Males and females 18 to 65 years of age, inclusive Have a body mass index (BMI) from 25.0 to 40.0 kg/m^2 Participant is judged by the investigator to be free from major comorbidities based upon medical history, physical examination, laboratory safety tests performed at screening and/or prior to administration of initial dose of study drug. Subjects can have a history of mild hyperlipidemia and/or mild hypertension but should

2018 Clinical Trials

64. Examining the Effects of Juice Fasting

Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Subjects considered as healthy by the investigator based on medical history and completion of the screening questionnaire. Subjects who, according to the investigator, can and will comply with the requirements of the protocol and are available for all scheduled visits at the investigational site. Healthy male or female aged between 18 and 35 (included) years 18.5 ≤BMI ≤ 30 kg/m² Ability to give their informed consent in writing Exclusion (...) Examining the Effects of Juice Fasting Examining the Effects of Juice Fasting - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Examining the Effects of Juice Fasting The safety and scientific validity

2018 Clinical Trials

65. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization doi:10.1016/j.jacc.2012.03.003 published online May 9, 2012; J. Am. Coll. Cardiol. Kirtane, L. Samuel Wann, and R. Parker Ward Robert O. Bonow, Charles E. Chambers, Paul S. Chan, Gregory J. Dehmer, Ajay J. Resonance, Society of Thoracic Surgeons, Manesh R. Patel, Steven R. Bailey, Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic of America, Heart Rhythm (...) 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2012.03.003 by on May 16, 2012 content.onlinejacc.org Downloaded from Appropriate Use Criteria Task Force Michael J. Wolk, MD, MACC, Chair Steven R. Bailey, MD, FACC, FSCAI, FAHA Pamela S. Douglas, MD, MACC, FAHA, FASE Robert C. Hendel, MD, FACC, FAHA, FASNC Christopher M. Kramer, MD, FACC, FAHA James K. Min, MD, FACC Manesh R. Patel, MD, FACC Leslee Shaw, PHD, FACC, FASNC Raymond F. Stainback, MD, FACC, FASE Joseph M. Allen, MA TABLE

2012 Society for Cardiovascular Angiography and Interventions

66. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

* Steven R. Bailey, MD, FACC, FSCAI§ Chirojit Mukherjee, MD†† John H. Calhoon, MD‡ Debabrata Mukherjee, MD, FACC* Blase A. Carabello, MD, FACC* Catherine M. Otto, MD, FACC* Milind Y. Desai, MBBS, FACC ¦¶ Carlos E. Ruiz, MD, PhD, FACC, FSCAI§ Fred H. Edwards, MD, FACC† Ralph L. Sacco, MD, MS, FAHA‡‡ Gary S. Francis, MD, FACC# Donnette Smith§§ Timothy J. Gardner, MD, FACC† James D. Thomas, MD, FACC ¦¦ ACCF Task Force Members Robert A. Harrington, MD, FACC, Chair Deepak L. Bhatt, MD, MPH, FACC, Vice Chair (...) ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update 1 © 2012 by the American College of Cardiology Foundation, the American Association for Thoracic Surgery, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement Developed in collaboration with the American Heart Association, American Society

2012 Society for Cardiovascular Angiography and Interventions

67. CCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

College of Cardiology Vol. 59, No. 9, 2012 © 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.001 Downloaded From: http://content.onlinejacc.org/ on 09/09/2014Appropriate Use Criteria Task Force Michael J. Wolk, MD, MACC, Chair Steven R. Bailey, MD, FACC, FSCAI, FAHA Pamela S. Douglas, MD, MACC, FAHA Robert C. Hendel, MD, FACC, FAHA, FASNC Christopher M. Kramer, MD, FACC, FAHA James K. Min, MD, FACC Manesh R. Patel, MD (...) , FACC Leslee Shaw, PHD, FACC, FASNC Raymond F. Stainback, MD, FACC, FASE Joseph M. Allen, MA TABLE OF CONTENTS Abstract 858 Preface 859 Introduction 859 Methods 860 Indication Development 860 Scope of Indications 860 Technical Panel Selection 861 Rating Process and Scoring 861 General Assumptions 862 De?nitions 862 Abbreviations 863 Results of Updated Ratings 864 Table A. Focused Update: New or Revised Indications 864 Coronary Revascularization Appropriate Use Criteria (By Indication) 865 Table 1

2012 Society for Cardiovascular Angiography and Interventions

68. Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals With Parkinson's Disease

of the auditory cues; absence of significant cognitive impairment (i.e., Mini-Mental Status Examination (MMSE) > 24; Frontal Assessment Battery (FAB) > 13); absence of psychiatric or severe systemic illnesses; mild-to-moderate disability assessed by means of the modified Hoehn and Yahr (H&Y) staging scale (1,5 ≤ H&Y ≤ 3); no engagement in any rehabilitative program in the 3 months before the beginning of the study Exclusion Criteria: Contacts and Locations Go to Information from the National Library (...) Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals With Parkinson's Disease Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals With Parkinson's Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2017 Clinical Trials

69. Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia

group receiving treatment of vitamin E and other group receiving placebo. The dose and duration of vitamin E treatment is 400 IU per day for 2 months. At the end of treatment, all subjects had to run the same medical interview, physical examination and blood test. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 69 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care (...) /ml Secondary Outcome Measures : Total Cholesterol [ Time Frame: 8 weeks ] mg/dl LDL Cholesterol [ Time Frame: 8 weeks ] mg/dl HDL Cholesterol [ Time Frame: 8 weeks ] mg/dl Triglycerides [ Time Frame: 8 weeks ] mg/dl Body weight [ Time Frame: 8 weeks ] kilograms Body Height [ Time Frame: 8 weeks ] centimeters BMI [ Time Frame: 8 weeks ] kg/m^2 Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk

2017 Clinical Trials

70. The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes

. Recruitment status was: Recruiting First Posted : February 23, 2017 Last Update Posted : February 23, 2017 Sponsor: Li-Li Chen Information provided by (Responsible Party): Li-Li Chen, China Medical University Hospital Study Details Study Description Go to Brief Summary: This study will be a randomized controlled trial aimed at examining the effectiveness of the in e-health education on shared care program for patients with type 2 diabetes mellitus (T2DM). The experiment will be conducted over 1 year (...) will be measured at three time points including 1 month before the experiment, and 2 and 5 months after the experiment. The self-management conditions and quality of life of the subjects will be also recorded using relevant scales. Condition or disease Intervention/treatment Phase Type 2 Diabetes Mellitus Behavioral: E-health Education Other: Routine care Not Applicable Detailed Description: This study will be a randomized controlled trial aimed at examining the effectiveness of the in e-health education

2017 Clinical Trials

71. Barriers and opportunities to implementation of sustainable e-Health programmes in Uganda: A literature review (PubMed)

was undertaken between May and December 2015 and was complemented with hand searching and a document review of grey literature in the form of policy documents and reports obtained online or from the Ministry of Health's Resource Centre.The searches identified a total of 293 resources of which 48 articles met the inclusion criteria of being in English and describing e-Health implementation in Uganda. These were included in the study and were examined in detail.Uganda has trialled several e-Health and m-Health (...) Barriers and opportunities to implementation of sustainable e-Health programmes in Uganda: A literature review Most developing countries, including Uganda, have embraced the use of e-Health and m-Health applications as a means to improve primary healthcare delivery and public health for their populace. In Uganda, the growth in the information and communications technology industry has benefited the rural communities and also created opportunities for new innovations, and their application

Full Text available with Trip Pro

2017 African journal of primary health care & family medicine

72. Examining the Effects of an Improvisation Group

. Kendall, P.C., Robin, J.A., Hedtke, K.A., Suveg, C., Flannery-Schroeder, E. & Gosch, E. (2005). Considering CBT with Anxious Youth? Think Exposures. Cognitive and Behavioural Practice, 12, 136-150. Kindler, R.C. & Gray, A.A. (2010). Theater and Therapy: How Improvisation Informs the Analytic Hour. Psychoanalytic Inquiry, 30, 254-266. doi: 10.1080/07351690903206223 Sheesley, A.P., Pfeffer, M. & Barish, B. (2016). Comedic Improv Therapy for the Treatment of Social Anxiety Disorder. Journal of Creativity (...) Examining the Effects of an Improvisation Group Examining the Effects of an Improvisation Group - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Examining the Effects of an Improvisation Group The safety

2017 Clinical Trials

73. Examining the Effects of a Team-based Running Program

patients. South African Journal of Sports Medicine. 2013;25(2):55. doi: 10.7196/SAJSM.481. Quelhas Martins A, Kavussanu M, Willoughby A, Ring C. Moderate intensity exercise facilitates working memory. Psychology of Sport and Exercise. 2013;14(3):323-328. doi: 10.1016/j.psychsport.2012.11.010 Dal Grande E, Taylor A, Wilson D. South australian health and wellbeing survey, december 2000. Centre for Population Studies in Epidemiology. 2002. Rosenberg M. Society and the adolescent self-image. Princeton, NJ (...) Examining the Effects of a Team-based Running Program Examining the Effects of a Team-based Running Program - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Examining the Effects of a Team-based Running

2017 Clinical Trials

74. AIUM Practice Parameter for the Performance of a Thyroid and Parathyroid Ultrasound Examination

-quality ultrasound examinations. The parameters re?ect what the AIUM considers the minimum criteria for a complete examination in each area but are not intended to establish a legal standard of care. AIUM-accredited practices are expected to generally follow the parameters with recognition that deviations from these parameters will be needed in some cases, depending on patient needs and available equipment. Practices are encouraged to go beyond the parameters to provide additional ser- vice (...) ) Committee.JAmCollRadiol 2015; 12: 1272–1279. 11. Burke CJ, Thomas RH, Howlett D. Imaging the major salivary glands. Br J Oral Maxillofac Surg 2011; 49:261–269. 12. Lee YY, Wong KT, King AD, Ahuja AT. Imaging of salivary gland tumours. Eur J Radiol 2008; 66:419–436. 13. Cornec D, Jousse-Joulin S, Pers JO, et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjogren’s syndrome: toward new diagnostic criteria? Arthritis Rheum 2013; 65:216–225. 14. Theander E, Mandl T. Primary Sjogren’s syndrome

2013 American Institute of Ultrasound in Medicine

75. AIUM Practice Parameter for the Performance of an Ultrasound Examination for Detection and Assessment of Developmental Dysplasia of the Hip

for the perfor- mance and recording of high-quality ultrasound examinations. The parameters re?ect what the AIUM considers the minimum criteria for a complete examination in each area but are not intended to establish a legal standard of care. AIUM-accredited practices are expected to generally follow the parameters with recognition that deviations from these parameters will be needed in some cases, depending on patient needs and available equipment. Practices are encouraged to go beyond the parameters (...) in the diagnosis of developmen- tal hip dysplasia. Radiology 2007; 242:355–359. 2. Smergel E, Losik SB, Rosenberg HK. Sonography of hip dysplasia. Ultrasound Q 2004; 20:201–216. 3. Bache CE, Clegg J, Herron M. Risk factors for developmental dys- plasia of the hip: ultrasonographic ?ndings in the neonatal period. J Pediatr Orthop B 2002; 11:212–218. 4. Mulpuri K, Song KM, Gross RH, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on detection and nonoperative management of pediatric

2013 American Institute of Ultrasound in Medicine

76. AIUM Practice Parameter for the Performance of Ultrasound Examinations of the Head and Neck

interests in medical diagnostic ultrasound, and, with hundreds of volunteers, the AIUM has promoted the safe and effective use of ultra- sound in clinical medicine for more than 50 years. This document and others like it will continue to advance this mission. Practice parameters of the AIUM are intended to provide the medical ultrasound community with parameters for the performance and recording of high-quality ultrasound examinations. The parameters reflect what the AIUM considers the minimum criteria (...) as follows: A. Salivary glands; B. Lymph nodes; C. Congenital lesions; D. Miscellaneous mass lesions; E. Infection and trauma; and F. Endocrine. The conditions listed within these categories represent some but not all of those encountered by the clinician who works in this area. V . Specifications for Individual Examinations A. Salivary Glands (Sublingual, Submandibular, and Parotid) 1. Indications for a salivary gland ultrasound examination include but are not limited to the following: • Diffuse

2013 American Institute of Ultrasound in Medicine

77. Effects of e-learning and m-learning in continuing education among nurses: an overview of systematic reviews (protocol)

Effects of e-learning and m-learning in continuing education among nurses: an overview of systematic reviews (protocol) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence (...) analgesics used in the clinic Full text-screening: As above, with the addition of: 7. No relevant outcome measure reported ">Prioritise the exclusion criteria Example: Two reviewers will independently extract data from each article. We first try to extract numerical data from tables, text or figures. If these are not reported, we will extract data from graphs using digital ruler software. In case data are not reported or unclear, we will attempt to contact authors by e-mail (max. 2 attempts). In case

2016 PROSPERO

78. AIUM Practice Parameter for the Performance of an Ultrasound Examination in the Practice of Urology

. The parameters reflect what the AIUM considers the minimum criteria for a complete examination in each area but are not intended to establish a legal standard of care. AIUM-accredited practices are expected to generally follow the parameters with recognition that deviations from these parameters will be needed in some cases, depending on patient needs and available equipment. Practices are encouraged to go beyond the parameters to provide additional service and information as needed. 14750 Sweitzer Ln, Suite (...) . Wasserman NF. Benign prostatic hyperplasia: a review and ultrasound classification. Radiol Clin North Am 2006; 44:689–710, viii. 21. Zalesky M, Urban M, Smerhovsky Z, Zachoval R, Lukes M, Heracek J. Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer . Int J Urol 2008; 15:68–75. C. Scrotal 1. Indications Indications for a scrotal ultrasound examination include but are not limited to: • Evaluation

2011 American Institute of Ultrasound in Medicine

79. E. Coli Nissle 1917

E. Coli Nissle 1917 E. Coli Nissle 1917 - Suspension for Infection Prophylaxis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. E. Coli Nissle 1917 - Suspension for Infection Prophylaxis (RONi) The safety (...) Summary: This study evaluates the long term effects of E. coli strain Nissle 1917 (EcN-Suspension) probiotic bacteria administration on the number of both, bacterial and viral infections during the first 24 months of infant's life. Half of study participants will receive EcN-Suspension, while the other half will receive placebo. In an additional non-clinical explorative evaluation will furthermore be investigated whether the early intestinal colonization with E.coli strain Nissle 1917 affects

2016 Clinical Trials

80. Acute Cardiorespiratory Effects of E-cigarette Inhalation

examination Normal EKG Normal blood tests Normal lung function Exclusion Criteria: Cardiovascular disease Respiratory disease Systemic or chronic disorders or disease Symptoms of infection or inflammation within 2 weeks of the study BMI≥30 Pregnancy Current habitual cigarette smokers Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor (...) Acute Cardiorespiratory Effects of E-cigarette Inhalation Acute Cardiorespiratory Effects of E-cigarette Inhalation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Acute Cardiorespiratory Effects of E

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>